NAV
Also available as an ETF (starting at the price of $1).
Management style
Asset class
Category
Risk / reward scale
Less
More
Investment minimum
NAV price
CUSIP | 921937736 |
---|---|
Management style | Index |
Asset class | International/Global Stock |
Category | Foreign Large Blend |
Inception date | 09/27/2011 |
Fund Number | 0570 |
YTD returns
This index fund provides investors with low-cost exposure to stock markets located outside the United States. The fund seeks to track an index that consists of companies located in developed markets, including Europe, the Pacific, and Canada, and in emerging markets. In addition to stock market risk, the fund is also subject to currency risk and country risk. Because of its exposure to emerging markets, the fund can be more volatile than other international funds. Long-term investors seeking exposure to non-U.S. markets may wish to consider this fund as part of a diversified portfolio.
Vanguard Equity Index Group
as of 12/31/2024
Recent returns
Average annual
Month-end | 3-Month total | YTD | 1-yr | 3-yr | 5-yr | 10-yr | Since inception 09/27/2011 | |
---|---|---|---|---|---|---|---|---|
VFWAX | -2.55% | -7.50% | 5.44% | 5.44% | 0.98% | 4.39% | 5.12% | 6.05% |
-1.90% | -7.50% | 5.80% | 5.80% | 1.17% | 4.53% | 5.18% | 6.14% |
as of 12/31/2024
Year | 1st Qtr | 2nd Qtr | 3rd Qtr | 4th Qtr | Year-end | |
---|---|---|---|---|---|---|
2024 | 4.70% | 0.77% | 8.03% | -7.50% | 5.44% | 5.80% |
2023 | 6.73% | 2.70% | -4.09% | 9.94% | 15.57% | 15.82% |
2022 | -6.03% | -12.50% | -10.54% | 14.87% | -15.50% | -15.49% |
2021 | 3.85% | 5.33% | -3.21% | 2.13% | 8.12% | 8.36% |
2020 | -23.69% | 17.46% | 6.32% | 16.85% | 11.35% | 11.22% |
2019 | 10.22% | 2.85% | -1.52% | 8.87% | 21.55% | 21.81% |
2018 | -0.47% | -3.26% | 0.90% | -11.42% | -13.95% | -14.13% |
2017 | 8.40% | 5.79% | 5.94% | 4.71% | 27.22% | 27.11% |
2016 | -0.29% | 0.28% | 6.62% | -1.73% | 4.77% | 4.80% |
2015 | 4.12% | 1.05% | -11.71% | 2.65% | -4.65% | -4.72% |
2014 | 0.39% | 5.15% | -5.25% | -4.07% | -4.05% | -3.31% |
as of 12/31/2024
Year | Capital return by NAV | Income return by NAV | Total return by NAV | |
---|---|---|---|---|
2024 | 2.18% | 3.26% | 5.44% | 5.80% |
2023 | 11.75% | 3.82% | 15.57% | 15.82% |
2022 | -18.07% | 2.57% | -15.50% | -15.49% |
2021 | 4.90% | 3.22% | 8.12% | 8.36% |
2020 | 8.86% | 2.49% | 11.35% | 11.22% |
2019 | 17.69% | 3.86% | 21.55% | 21.81% |
2018 | -16.46% | 2.52% | -13.95% | -14.13% |
2017 | 23.67% | 3.55% | 27.22% | 27.11% |
2016 | 1.67% | 3.10% | 4.77% | 4.80% |
2015 | -7.25% | 2.59% | -4.65% | -4.72% |
2014 | -7.17% | 3.12% | -4.05% | -3.31% |
2013 | 11.20% | 3.28% | 14.49% | 15.31% |
2012 | 15.00% | 3.52% | 18.52% | 17.48% |
2011 | -1.88% | 3.51% | 1.63% | — |
as of 12/31/2024
1-yr | 3-yr | 5-yr | 10-yr | Since inception 09/27/2011 | |
---|---|---|---|---|---|
VFWAX | 5.44% | 2.97% | 23.96% | 64.78% | 118.03% |
5.80% | 3.56% | 24.82% | 65.72% | — |
VFWAX
0.11%
Average expense ratio of similar funds2
0.87%
Purchase fee
None
Fund family redemption fee
None
None
The performance data shown represent past performance, which is not a guarantee of future results. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data cited.
Performance data do not reflect the deduction of the $25 annual account service fee that may be applied to certain accounts. If this fee was included, performance would be lower.
NAV
NAV change
52-week High
52-week Low
52-week Difference
Name | Date | NAV |
---|---|---|
VFWAX | 01/17/2025 | $36.05 |
This chart can’t be displayed on mobile devices. For the best viewing experience, visit this page from your desktop or laptop.
as of 12/31/2024
Fundamental | VFWAX | |
---|---|---|
Number of stocks | 3831 | 3702 |
Median market cap | $43.9 B | $43.9 B |
Earnings growth rate | 14.0% | 14.0% |
Short-term reserves | — | — |
P/E ratio | 15.5x | 15.5x |
P/B ratio | 1.8x | 1.8x |
Turnover rate (Fiscal Year-end 10/31/2024) | 4.8% | — |
Return on equity | 12.1% | 12.1% |
Foreign holdings | 99.1% | — |
Fund total net assets as of 12/31/2024 | $55.8 B | — |
Share class total net assets | $8.3 B | — |
as of 12/31/2024
Weighted equity exposures exclude any temporary cash investments and equity index futures. Some short-term fixed income securities are classified as cash and are excluded from the weighted bond exposures.
as of 12/31/2024
Ticker | Holdings | Shares | Market value |
---|---|---|---|
2330 | Taiwan Semiconductor Manufacturing Co. Ltd. | 48,428,873 | $1,573,939,480 |
700 | Tencent Holdings Ltd. | 12,489,904 | $666,621,417 |
ASML | ASML Holding NV | 793,585 | $555,854,082 |
SAP | SAP SE | 2,212,451 | $544,205,634 |
NOVO B | Novo Nordisk A/S Class B | 6,230,936 | $537,616,557 |
7203 | Toyota Motor Corp. | 23,342,835 | $455,774,322 |
NESN | Nestle SA | 5,188,982 | $425,720,510 |
AZN | AstraZeneca plc | 3,021,798 | $393,980,814 |
NOVN | Novartis AG | 4,032,578 | $392,600,619 |
ROG | Roche Holding AG | 1,396,046 | $390,343,690 |
Ticker | Holdings | Shares | Market value |
---|---|---|---|
2330 | Taiwan Semiconductor Manufacturing Co. Ltd. | 48,428,873 | $1,573,939,480 |
700 | Tencent Holdings Ltd. | 12,489,904 | $666,621,417 |
ASML | ASML Holding NV | 793,585 | $555,854,082 |
SAP | SAP SE | 2,212,451 | $544,205,634 |
NOVO B | Novo Nordisk A/S Class B | 6,230,936 | $537,616,557 |
7203 | Toyota Motor Corp. | 23,342,835 | $455,774,322 |
NESN | Nestle SA | 5,188,982 | $425,720,510 |
AZN | AstraZeneca plc | 3,021,798 | $393,980,814 |
NOVN | Novartis AG | 4,032,578 | $392,600,619 |
ROG | Roche Holding AG | 1,396,046 | $390,343,690 |
Ticker | Holdings | Shares | Market value |
---|---|---|---|
2330 | Taiwan Semiconductor Manufacturing Co. Ltd. | 48,428,873 | $1,573,939,480 |
700 | Tencent Holdings Ltd. | 12,489,904 | $666,621,417 |
ASML | ASML Holding NV | 793,585 | $555,854,082 |
SAP | SAP SE | 2,212,451 | $544,205,634 |
NOVO B | Novo Nordisk A/S Class B | 6,230,936 | $537,616,557 |
7203 | Toyota Motor Corp. | 23,342,835 | $455,774,322 |
NESN | Nestle SA | 5,188,982 | $425,720,510 |
AZN | AstraZeneca plc | 3,021,798 | $393,980,814 |
NOVN | Novartis AG | 4,032,578 | $392,600,619 |
ROG | Roche Holding AG | 1,396,046 | $390,343,690 |
Realized gain
% of NAV
Unrealized gains of NAV
% of NAV
Fiscal year end
Distribution schedule
A fund's capital gains and losses can reveal the tax implications of holding a particular fund in a taxable account. This is true of both realized and unrealized capital gains and losses.
Learn about realized and unrealized gains and lossesA fund's capital gains and losses can reveal the tax implications of holding a particular fund in a taxable account. This is true of both realized and unrealized capital gains and losses.
Learn about realized and unrealized gains and lossesPerformance & fees
Most recent data available. © 2023 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; (3) does not constitute investment advice offered by Morningstar; and (4) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
R-squared and beta are calculated from trailing 36-month fund returns relative to the associated benchmark.
© 2023 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Vanguard average mutual fund expense ratio: 0.09%. Industry average mutual fund expense ratio: 0.50%. All averages are asset-weighted. Industry average excludes Vanguard. Sources: Vanguard and Morningstar, Inc., as of December 31, 2023.
Total returns: Short-term total return information is provided only as a service. Historical performance—particularly short-term performance—is no guarantee of future returns. Price, yield, and return on an actual investment will fluctuate, and you may have a gain or loss when you sell. Average annual returns include changes in price and reinvestments of dividends and capital gains. Since-inception returns for less than 1 year and year-to-date returns aren't annualized. Index performance is provided as a benchmark but isn't illustrative of any particular investment. You can't invest in an index.
Standardized returns: To see quarterly fee-adjusted returns, refer to the Price & Performance details.
Expense ratios: Expense ratios are displayed on Overview. For investments that are less than 1 fiscal year old, expense ratios are estimated.
Risk: All investing is subject to risk, including the possible loss of the money you invest. Funds that concentrate on a relatively narrow market sector face the risk of higher share-price volatility. Investments in stocks or bonds issued by non-U.S. companies are subject to risks including country/regional risk and currency risk.
An investment in the fund could lose money over short or even long periods. You should expect the fund’s share price and total return to fluctuate within a wide range, like the fluctuations of the overall stock market. The fund’s performance could be hurt by: